2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
7
Prostatic Neoplasms
5
Brain Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Radiation Injuries
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hemangioma
2
Breast Neoplasms
2
Urogenital Neoplasms
1
Scleroderma, Localized
1
Respiratory Distress Syndrome
1
Radiation Pneumonitis
1
Popliteal Cyst
1
Polycystic Ovary Syndrome
1
Pneumonia, Viral
1
Pneumonia
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Optic Neuritis
1
Neurodermatitis
1
Neoplastic Cells, Circulating
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Interventions
siltuximab
4
tocilizumab
3
fludarabine
3
Cyclophosphamide
3
fludarabine phosphate
2
Interleukin 1 Receptor Antagonist Protein
2
AP 1903 reagent
2
talquetamab
1
otelixizumab
1
obinutuzumab
1
lopinavir-ritonavir drug combination
1
glofitamab
1
axicabtagene ciloleucel
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Oxaliplatin
1
Neuropsychological Tests
1
Metoprolol
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lopinavir
1
Leukapheresis
1
Infliximab
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Gemcitabine
1
Gelsolin
1
Etanercept
1
Dexamethasone
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Adrenal Cortex Hormones
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled